When you think of high blood pressure, lifestyle choices around nutrition or exercise may come to mind—not your hormones. But ...
AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive ...
New drug Baxdrostat lowers stubborn high blood pressure in difficult-to-treat patients, showing promising results in a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results